Stay updated on APL-2 Efficacy & Safety in PNH Patients Clinical Trial
Sign up to get notified when there's something new on the APL-2 Efficacy & Safety in PNH Patients Clinical Trial page.

Latest updates to the APL-2 Efficacy & Safety in PNH Patients Clinical Trial page
- CheckyesterdayChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check8 days agoChange DetectedA site-wide NIH banner announces updates and FAQs about the agency’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check15 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2 on the page displaying a 403 Forbidden error.SummaryDifference0.2%

- Check22 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 while the study record remains unavailable behind a 403 Forbidden page.SummaryDifference0.2%

- Check43 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the expected study record with a standard error screen; the site chrome is shown, indicating an access permissions issue rather than updated study details.SummaryDifference20%

- Check50 days agoChange DetectedNo additions or deletions were reported for this page in the provided data.SummaryDifference0.0%

Stay in the know with updates to APL-2 Efficacy & Safety in PNH Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APL-2 Efficacy & Safety in PNH Patients Clinical Trial page.